These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 8380103

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M, Garbuglia AR, Benedetto A, Cappiello T, Leoncini L, Migliore G, Agarossi A, Syrjänen K, DIANAIDS Collaborative Study Group.
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Regional distribution of human papillomavirus DNA and other risk factors for invasive cervical cancer in Panama.
    Acs J, Hildesheim A, Reeves WC, Brenes M, Brinton L, Lavery C, de la Guardia ME, Godoy J, Rawls WE.
    Cancer Res; 1989 Oct 15; 49(20):5725-9. PubMed ID: 2551495
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A population-based seroepidemiological study of cervical cancer.
    Dillner J, Lenner P, Lehtinen M, Eklund C, Heino P, Wiklund F, Hallmans G, Stendahl U.
    Cancer Res; 1994 Jan 01; 54(1):134-41. PubMed ID: 8261434
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
    Hildesheim A, Schiffman M, Scott DR, Marti D, Kissner T, Sherman ME, Glass AG, Manos MM, Lorincz AT, Kurman RJ, Buckland J, Rush BB, Carrington M.
    Cancer Epidemiol Biomarkers Prev; 1998 Nov 01; 7(11):1035-41. PubMed ID: 9829713
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human papillomavirus type and tobacco use as predictors of survival in early stage cervical carcinoma.
    Wright JD, Li J, Gerhard DS, Zhang Z, Huettner PC, Powell MA, Gibb RK, Herzog TJ, Mutch DG, Trinkaus KM, Rader JS.
    Gynecol Oncol; 2005 Jul 01; 98(1):84-91. PubMed ID: 15894364
    [Abstract] [Full Text] [Related]

  • 15. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
    Shields TS, Brinton LA, Burk RD, Wang SS, Weinstein SJ, Ziegler RG, Studentsov YY, McAdams M, Schiffman M.
    Cancer Epidemiol Biomarkers Prev; 2004 Oct 01; 13(10):1574-82. PubMed ID: 15466972
    [Abstract] [Full Text] [Related]

  • 16. A population-based study of squamous cell vaginal cancer: HPV and cofactors.
    Daling JR, Madeleine MM, Schwartz SM, Shera KA, Carter JJ, McKnight B, Porter PL, Galloway DA, McDougall JK, Tamimi H.
    Gynecol Oncol; 2002 Feb 01; 84(2):263-70. PubMed ID: 11812085
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile.
    Ferreccio C, Prado RB, Luzoro AV, Ampuero SL, Snijders PJ, Meijer CJ, Vaccarella SV, Jara AT, Puschel KI, Robles SC, Herrero R, Franceschi SF, Ojeda JM.
    Cancer Epidemiol Biomarkers Prev; 2004 Dec 01; 13(12):2271-6. PubMed ID: 15598792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.